Indinavir: Clinical Trials

12 trials of Indinavir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Completed 12
Phase 22Completed 2

Follow Indinavir: new trials by email Literature Review of Indinavir trials Research Report on Indinavir

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
indinavir/ritonavir - HIV Infections, Tuberculosis
Phase 1 / Phase 2CompletedThe HIV Netherlands Australia Thailand Research Collaboration202006-12-012020-07-17
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Nevirapine, Efavirenz, Indinavir/ritonavir - HIV Infections
Phase 1CompletedGermans Trias i Pujol Hospital6752005-01-012019-12-04
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
Indinavir, Zidovudine, Lamivudine - HIV Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)421997-03-032017-07-02
A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
indinavir (MK-0639) - Acquired Immunodeficiency Syndrome, HIV Infections
Phase 1CompletedNational Cancer Institute (NCI)631995-07-012008-03-04
Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
Indinavir sulfate, Ritonavir, Amlodipine - HIV Infections, Cardiovascular Diseases
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)322021-11-01
Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults
Indinavir sulfate, Rifabutin - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)312021-10-29
Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir
Indinavir sulfate, Ritonavir - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)502021-11-01
A Study of 141W94 in Combination With Other Anti-HIV Drugs
Indinavir sulfate, Amprenavir, Nelfinavir mesylate - HIV Infections
Phase 1CompletedGlaxo Wellcome482005-06-24
A Study of L-735,524 in HIV-Positive Children and Adolescents
Indinavir sulfate - HIV Infections
Phase 1CompletedMerck Sharp & Dohme LLC122005-06-24
Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment
indinavir sulfate, ritonavir - HIV Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)292021-11-01
A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
Indinavir sulfate, Lamivudine, Zidovudine - HIV Infections, Pregnancy
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)242021-10-29
Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
Indinavir sulfate, Lamivudine, Stavudine - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)242021-10-28

Conditions studied

HIV Infections (12)  ·  Acquired Immunodeficiency Syndrome (2)  ·  AIDS-Related Complex (1)  ·  Cardiovascular Diseases (1)  ·  Hypertension (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Pregnancy Complications, Infectious (1)  ·  Tuberculosis (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Germans Trias i Pujol Hospital (1)  ·  Glaxo Wellcome (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Cancer Institute (NCI) (1)  ·  The HIV Netherlands Australia Thailand Research Collaboration (1)

Countries

United States (10)  ·  Puerto Rico (2)  ·  Spain (1)  ·  Thailand (1)

Top investigators

Bonaventura Clotet, MD, PhD (1)  ·  Charles Flexner (1)  ·  Constance Benson (1)  ·  Diana Wara (1)  ·  Edward P. Acosta (1)  ·  Elaine Abrams (1)  ·  Ellen Chadwick (1)  ·  John G. Gerber (1)  ·  John Sleasman (1)  ·  Judith Currier (1)  ·  Kiat Ruxrungtham, MD (1)  ·  Marshall Glesby (1)  ·  Ram Yogev (1)  ·  Ross McKinney (1)  ·  Ruth Tuomala (1)

Results publications

PMID 15483465, PMID 15958837, PMID 16084849, PMID 16583266, PMID 22250979, PMID 23494984, PMID 26832753

NIH funding

2004 (1)